Insider buying last 90 days
No open-market insider purchases were filed for MGTX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MGTX insider filing, plotted on the chart in Gekko.Open MGTX in Gekko
NASDAQ: MGTX
MeiraGTx (MGTX) Stock Analysis & Forecast
Oct 12 close
$10.38−0.31 (−2.9%)
Gekko Brief
AI summaryOct 12 closeThis week's news around MeiraGTx centers on insider activity and board changes rather than operational results. Chief Scientific Officer Stuart Naylor sold 27,659 shares worth approximately $294,291 through a pre-adopted trading plan, continuing a pattern described as insider selling with no corresponding buys over the past year. Separately, the company appointed Alan M. Sebulsky to its board, bringing decades of investment and financial strategy experience as MeiraGTx transitions from clinical development toward commercial operations for its gene therapies. One technical analysis piece flagged weak near and mid-term sentiment alongside a more constructive long-term view.
MGTX closed at $10.38, down 2.9%, sitting between its 50-day average of $12.73 and 200-day average of $10.17. The stock is down 18.8% over one month and 16.6% over three months, though up 7.8% over six months and 18.5% over the past year. The GekkoIndex reads 69.3, placing the stock in the Accumulation zone, though the index has slipped 4.1 points over five days. Price sits 41.2% below Gekko Fair Value of $17.66.
The next earnings report is scheduled for 12 November, 30 days out, placing it just beyond a typical 20-trading-day window. Historically, MGTX has beaten EPS estimates in 3 of 8 quarters, with an average absolute reaction of 7.1% around reports. Seasonality from this calendar point shows a 24.6% average move over the next 20 trading days across 5 years, with gains in 4 of those years. Analyst consensus stands at 4 buy, 1 hold, with a consensus target of $27.75.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
MeiraGTx price vs fair value
Close $10.38200-day averageGekko Fair Value $17.66
MeiraGTx quick facts
- Market cap
- $961.3M
- P/E ratio
- 12.1
- Forward P/E
- 64.1
- EPS, TTM
- $0.87
- Revenue, TTM
- $397.5M
- Profit margin
- 19.9%
- Dividend yield
- —
- Beta
- 1.35
- Volume
- 506,494 avg 1.12M
- 1-year return
- +18.5%
- Typical daily move
- ±5.6%
- Typical 20-day move
- ±10.3%
- 50-day average
- $12.73
- 200-day average
- $10.17
- Next earnings
- Nov 12 before open
- Shares outstanding
- 96.04M
MeiraGTx swing-trade checklist
MeiraGTx scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
- Trendmixed
Averages disagree
Close $10.38 sits between the 50-day ($12.73) and 200-day ($10.17) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
69.3, Accumulation
Reading 69.3 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
41.2% below
Price is 41.2% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 31 days
Next report Nov 12, 2026, 31 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+24.6% on average
From this point in the calendar, the next 20 trading days averaged +24.6% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
MeiraGTx stock chart and price history
MeiraGTx closed at $10.38 on Oct 12, 2026, +18.5% over the past year, inside a 52-week range of $6.62 to $15.35.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −18.8%
- 3 months
- −16.6%
- 6 months
- +7.8%
- 1 year
- +18.5%
The full MGTX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MGTX in Gekko
Follow MeiraGTx through every session
Put MGTX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MGTX in GekkoFree for 7 days. No credit card required.
About MeiraGTx
MeiraGTx works on gene therapy while still in the clinical stage, aiming to treat patients with serious and often hard-to-manage diseases. Its research covers eye conditions such as inherited blindness, dry mouth that can follow radiation treatment for head and neck cancers, and degenerative brain diseases including ALS and Parkinson's. The company has become known for applying gene therapy approaches across this unusually wide mix of conditions.
Several programs are already in Phase 1/2 trials, covering Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, radiation-induced xerostomia, and Parkinson's, while a trial for xerostomia tied to Sjogren's syndrome is being readied and other neurodegenerative work remains at the preclinical stage. MeiraGTx also partners with Janssen Pharmaceuticals, Inc. on gene therapies that can be switched on or off, built around its own riboswitch technology.
MeiraGTx was founded in 2015 and is based in New York, New York. Its shares are listed on the NASDAQ under the ticker MGTX.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Biotechnology
- Website
- meiragtx.com
MeiraGTx GekkoIndex: the smart money zone
MeiraGTx’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.3, in the Accumulation zone, down 4.1 points over five sessions.
69.3Accumulation
Down 4.1 points over five sessions, from the Buying zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 31 | −0.1% | +14.9% | ||
| Accumulation (current zone) | 200 | +1.9% | +5.2% | ||
| Neutral | 399 | +0.1% | +2.1% | ||
| Distribution | 45 | +2.2% | −3.7% | ||
| Selling | 7 | Too few readings yet | |||
Average MGTX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the MGTX price, zone by zone.Track MGTX in Gekko
Is MeiraGTx stock overvalued? Gekko Fair Value
MeiraGTx trades 41.2% below Gekko Fair Value of $17.66, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what MeiraGTx shares are worth, recalculated every trading day.
$17.66
Gekko Fair Value, Oct 10, 2026
41.2% Undervalued
At the end of Aug 2026 the price was 41.7% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open MGTX in Gekko
MeiraGTx insider and Congress trading
No open-market insider purchases were filed for MeiraGTx, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in MGTX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for MGTX, plotted on the chart in Gekko.Open MGTX in Gekko
Buybacks
MeiraGTx has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $18.19M
- As a share of market cap
- 1.89%
From company filings.
MeiraGTx earnings: next date and track record
MeiraGTx reports on Nov 12, 2026, before the open (31 days away), and beat the EPS estimate in 3 of its last 8 reports.
Next earnings report
Nov 12, 2026
Expected before the open, 31 days away
- EPS estimate
- −$0.46
- Revenue estimate
- $6.95M
3 of 8reports beat the EPS estimate
±7.1%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 13, 2026 | $1.71 est −$0.46 | $321.4M est $700K | +4.3% |
| May 14, 2026 | −$0.57 est −$0.43 | $293K est $17.00M | −5.7% |
| Mar 26, 2026 | $0.19 est −$0.60 | $75.36M est $1.45M | 0.0% |
| Nov 13, 2025 | −$0.62 est −$0.50 | $410K est $3.87M | −5.4% |
| Aug 14, 2025 | −$0.48 est −$0.52 | $3.69M est $6.48M | −2.0% |
| May 13, 2025 | −$0.51 est −$0.38 | $1.93M est $4.44M | −17.4% |
| Mar 13, 2025 | −$0.50 est −$0.48 | $21.39M est $1.50M | +21.5% |
| Nov 13, 2024 | −$0.54 est −$0.47 | $10.91M est $1.62M | −0.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
MeiraGTx stock forecast and analyst price targets
Analysts’ average 12-month price target for MeiraGTx is $27.75, +167.3% from the last close, from 5 firms rating the stock in the last 90 days.
$27.75consensus 12-month target, +167.3% from the last close
Now $10.38Avg $27.75
Low $16High $30
Each firm’s latest rating in the last 90 days: 5 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 24 | Goldman Sachs | $16 | +54.1% |
| Aug 17 | Piper Sandler | $30 | +189.0% |
| Aug 14 | Bank of America Securities | $19 | +83.0% |
| Aug 14 | H.C. Wainwright | $20 | +92.7% |
| Aug 13 | RBC Capital | $27 | +160.1% |
+5.2%average 20-day move after past Accumulation readings
+24.6%average move over the next 20 trading days in the last 5 years
±5.6%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
MeiraGTx seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, MeiraGTx averaged +24.6% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +19.0% | 3 of 5 |
| Next 10 trading days | +18.7% | 3 of 5 |
| Next 15 trading days | +22.2% | 3 of 5 |
| Next 20 trading days | +24.6% | 4 of 5 |
| Next 30 trading days | +15.8% | 3 of 5 |
For scale, MGTX’s typical 20-trading-day move in either direction is about 10.3%.
MeiraGTx market cap and key statistics
MeiraGTx’s market cap is $961.3M, with a P/E ratio of 12.1 and revenue of $397.5M over the last twelve months.
Valuation
- Market cap
- $961.3M
- P/E ratio
- 12.1
- Forward P/E
- 64.1
- EPS, TTM
- $0.87
- Gekko Fair Value
- $17.66
Trading
- Volume
- 506,494
- Avg volume, 20 days
- 1.12M
- 52-week high
- $15.35
- 52-week low
- $6.62
- Shares outstanding
- 96.04M
Financials
- Revenue, TTM
- $397.5M
- Profit margin
- 19.9%
- Return on equity
- 72.2%
- Quarterly earnings growth, YoY
- 0.0%
Risk and income
- Beta
- 1.35
- Typical daily move
- ±5.6%
- Typical 20-day move
- ±10.3%
MeiraGTx stock news this week
Coverage of MeiraGTx this week reads neutral: 1 positive, 5 neutral and 2 negative headlines.
- Form 144 MeiraGTx Holdings plc For: 11 October By Investing.comInvesting.com South Africa, Oct 11
- Form 4 MeiraGTx Holdings PLC For: 11 October By Investing.comInvesting.com South Africa, Oct 11
- MeiraGTx chief scientific officer Naylor sells $294,291 in sharesInvesting.com, Oct 11
- Form 4 MeiraGTx Holdings PLC For: 6 October By Investing.comInvesting.com Canada, Oct 7
- MeiraGTx Holdings PLC (MGTX) Insider Stuart Naylor Sells 27,659 SharesGuruFocus, Oct 7
- Officer Stuart Naylor proposes selling 27,659 MeiraGTx (NASDAQ: MGTX) shares worth $294K.Stock Titan, Oct 7
MeiraGTx peers
MeiraGTx’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AMGNAmgen | Neutral | 25.5% below |
| GILDGilead Sciences | Neutral | 4.2% above |
| MRNAModerna | Neutral | 62.7% above |
| NTRANatera | Neutral | 10.3% above |
| IQVIQVIA | Neutral | 8.4% above |
| UTHRUnited Therapeutics | Neutral | 14.4% below |
A peer links to its own page where one exists.
MeiraGTx stock FAQ
What is MeiraGTx’s market cap?
MeiraGTx’s market cap is $961.3M at the Oct 12, 2026 close of $10.38, with 96.04M shares outstanding. The shares trade on a P/E ratio of 12.1.
What is the MeiraGTx stock forecast?
The consensus analyst 12-month price target for MeiraGTx is $27.75, +167.3% from the last close. Of the 5 firms that rated the stock in the last 90 days, 4 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is MeiraGTx stock overvalued or undervalued?
On Gekko’s estimate MeiraGTx is undervalued: the Oct 12, 2026 close of $10.38 is 41.2% below Gekko Fair Value of $17.66. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does MeiraGTx report earnings next?
MeiraGTx is expected to report on Nov 12, 2026, before the market opens (31 days away). Analysts expect earnings of −$0.46 per share on revenue of $6.95M. MeiraGTx beat the earnings estimate in 3 of its last 8 reports, moving 7.1% on average across the report.
What is MeiraGTx’s 52-week high and low?
MeiraGTx’s 52-week high is $15.35 and its 52-week low is $6.62; it closed at $10.38 on Oct 12, 2026, +18.5% over the past year. Over the last five years the shares peaked at $24.89 on Dec 28, 2021.
Is MeiraGTx stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See MeiraGTx the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.